A recent study indicated that CysC at 24 h is the most effective biomarker for diagnosing CIN, although baseline levels of other prevalent biomarkers, including serum IL-18, β-2M, and TNFα, are the most reliable prognostic indicators [39]. Here, B2M is linked to cervical squamous intraepithelial neoplasia.